A CNBC reporter since 1990, Bob Pisani has covered Wall Street and the stock market for nearly 20 years. Pisani covered the real estate market for CNBC from 1990-1995, then moved on to cover corporate management issues before becoming Stocks Correspondent in 1997.
In addition to covering the global stock market, he also covers initial public offerings (IPOs), exchange-traded funds (ETFs) and financial market structure for CNBC.
In 2013, he won Third Place in the National Headliner Awards in the Business and Consumer Reporting category for his documentary on the diamond business, "The Diamond Rush."
In 2014, Pisani was honored with a Recognition Award from the Market Technicians Association for "steadfast efforts to integrate technical analysis into financial decision making, journalism and reporting."
Prior to joining CNBC, Pisani co-authored "Investing in Land: How to Be a Successful Developer." He and his father taught a course in real estate development at the Wharton School of Business at the University of Pennsylvania from 1987-1992. Pisani learned the real estate business from his father, Ralph Pisani, a retired real estate developer.
Follow Bob Pisani on Twitter @BobPisani.
No surprise that the small-cap Russell 2000, down 2.5 percent, is the downside leader of the major indices; since the current leg of the market rally began on September 1, the Russell has far outperformed, up 31 percent vs. the up 22 percent of the S&P 500.
Grains continue to explode: corn up another 1.6 percent today. Cotton, wheat, sugar, hogs, rice all higher — and things like rice actually outperforming stock markets (up 3.5 percent year to date). There's the weak dollar trade and Australian damage to wheat.
Here's what traders are watching as we get closer to the first presidential debate on Monday.
There's more than meets the eye to today's rally.
Fed leaves rates unchanged, traders wonder what's really keeping rates on hold.
After many false starts, we're finally starting to see the IPO market gain ground.
Not all buybacks have the same relative impact on actual returns to shareholders, based on CNBC's analysis.
A Fed hike may be the only solution for stopping the yen strength that's weighing on Japan's economic growth.
The company's lead Alzheimer's candidate is similar to the product that disappointed in a competitor's clinical trials.